In June 2022, the Government of Canada established a long-term agreement with Moderna for the domestic production of messenger RNA (mRNA) vaccines in Canada.
GVI Clinical Development Solutions
GVI Clinical Development Solutions (CDS) is an innovative contract research organization focused on quality, timeliness, and cost-effective services. The company is committed to delivering excellence in clinical development services, and is experienced in cardiovascular and metabolic disease fields.
CDS's flexibility and active participation in the critical stages of the clinical development process makes it an ideal partner for emerging life science companies, academic institutes, and public health organizations carrying out their own clinical trials. CDS is proud to say it consistently delivers.
Please visit CDS's website for more information on its clinical project management, clinical trial monitoring, clinical trial and drug safety evaluation, clinical site document management, regulatory affairs, and clinical quality assurance and data management services.